| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.88B | 1.84B | 2.04B | 2.48B | 967.43M | 861.20M |
| Gross Profit | 336.66M | 358.07M | 355.21M | 294.97M | 177.25M | 161.87M |
| EBITDA | 130.37M | 142.13M | 131.35M | 106.03M | 70.26M | 65.07M |
| Net Income | 66.17M | 76.10M | 71.04M | 68.43M | 35.47M | 32.58M |
Balance Sheet | ||||||
| Total Assets | 662.45M | 736.39M | 651.39M | 794.74M | 465.79M | 462.66M |
| Cash, Cash Equivalents and Short-Term Investments | 90.89M | 79.02M | 57.83M | 193.80M | 29.65M | 25.06M |
| Total Debt | 234.77M | 194.88M | 180.33M | 90.38M | 99.98M | 96.47M |
| Total Liabilities | 430.89M | 484.88M | 418.76M | 564.03M | 260.21M | 250.29M |
| Stockholders Equity | 231.56M | 251.51M | 232.63M | 230.71M | 206.48M | 212.82M |
Cash Flow | ||||||
| Free Cash Flow | 109.39M | 91.58M | -144.98M | 221.11M | 38.86M | 31.41M |
| Operating Cash Flow | 109.74M | 108.75M | -132.49M | 232.13M | 48.80M | 41.45M |
| Investing Cash Flow | -71.43M | -26.08M | -8.15M | -11.52M | -8.38M | -9.94M |
| Financing Cash Flow | -18.24M | -61.48M | 4.66M | -57.16M | -35.12M | -50.07M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £29.92B | 16.49 | 7.09% | 2.98% | 1.78% | -50.72% | |
73 Outperform | £281.49M | ― | 46.72% | 4.14% | 16.62% | -7.97% | |
70 Outperform | £133.28M | 12.63 | 4.35% | 4.38% | 7.70% | -5.33% | |
69 Neutral | £2.88B | 0.40 | 3.94% | 2.78% | -19.04% | -34.52% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
63 Neutral | £1.00B | 21.07 | 27.40% | 7.01% | 1.71% | -12.49% | |
59 Neutral | £9.12B | -112.68 | 1.68% | 2.86% | -4.82% | -123.58% |